Product: | Vildagliptin | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 17762 | ||||||||
CAS Number: | 274901-16-5 | ||||||||
Pricing: |
|
||||||||
Formula: | C17H25N3O2 | ||||||||
Chemical Purity: | 99.8% | ||||||||
Molecular Weight: | 303.20 | ||||||||
Structure: | |||||||||
Appearance: | White solid | ||||||||
Category: | Anti-cancer compounds | ||||||||
Stability: | Stable under recommended storage conditions | ||||||||
Storage: |
Store at -20° C |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
Ahrén, B; Landin-Olsson, M; Jansson, PA; Svensson, M; Holmes, D; Schweizer, A., Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism, 2004, 89 (5): 2078–84.; Mentlein, R; Gallwitz, B; Schmidt, WE, Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. European journal of biochemistry / FEBS, 1993, 214 (3): 829–35. |
||||||||
MSDS: | |||||||||
Applications: | An anti-hyperglycemic agent used to treat hyperglycemia in type 2 diabetes. A dipeptidyl peptidase-4 inhibitor. Allows for the secretion of insulin in the beta cells and suppresses glucagon release by the alpha cells of the islets of Langerhans in the pancrease. |